Bryanlgh Heart Institute

Lincoln, Nebraska 68516

0 studies enrolling now · 21 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction, Angina Pectoris, Atrial Fibrillation, Cardiomyopathies, Cardiovascular Diseases, Carotid Artery Disease, Central Sleep Apnea, Cheyne Stokes Respiration, Chronic Heart Failure, Congestive Heart Failure, Coronary Artery Disease

Studies at this site

• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• Heart Failure Exercise And Resistance Training Camp (HEART Camp) — Completed
• Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy — Completed
• Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy — Completed
• SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy — Completed
• Examining Heart Attacks in Young Women — Completed
• CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients — Completed
• Chronic Evaluation of Respicardia Therapy — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• NAVISTAR® THERMOCOOL® SF Catheter: Observational Study — Completed
• Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg — Completed
• Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization — Status unconfirmed
• Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf) — Completed
• Paracor Ventricular Support System (PVSS) for Patients With Heart Failure — Stopped early
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
• Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure. — Completed
• Protect II, A Prospective, Multicenter Randomized Controlled Trial — Stopped early
• ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure — Stopped early
• A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack — Stopped early